Blog

Strados Labs Awarded Competitive Small Business Innovation Grant from the National Science Foundation

August 18, 2020

Strados Labs has been awarded a National Science Foundation (NSF) Phase I Small Business Innovation Research (SBIR) grant for $224,470 to conduct research and development (R&D) work on a smart wearable platform for remote respiratory monitoring: building better technologies for telemedicine in the age of COVID-19. This leading-edge technology from Strados Labs is used to […]

Read More

Mobile Platform Partners with Companies to Launch Rent Relief Program

August 13, 2020

The owner of a mobile platform is stepping up to help families struggling to pay their rent amid the coronavirus pandemic. Ofo Ezeugwu, the CEO and founder of Whose Your Landlord, has partnered with Walmart and other companies on a rent relief program. He said he is targeting his efforts toward Black households because they […]

Read More

InfraScan Inc. Announces Issuance of US Patents for Brain Diagnosis

August 4, 2020

InfraScan, a medical device firm specializing in brain injury and stroke diagnostic products, announced today the issuance by the US Patent Office of three additional patents that cover internal bleeding, brain trauma and stroke detection technologies. The first patent for invention number US 2020/0229712 A1 is for an optical probe for oximetry measurements. The second […]

Read More

This Tech CEO Raised a $1M Seed Round While Treating Covid-19 patients, and Relying on Her Own Product

July 29, 2020

During the height of the Covid-19 pandemic in Philadelphia, tech entrepreneur Dr. Subha Airan-Javiaspent weeks taking care of recovering Covid-19 patients at a local long-term acute care facility. Not only did she and her fellow clinicians rely on the product she created, in-patient workflow management app TrekIT Health, she was also busy raising a $1 […]

Read More

Biopharma Tackles COVID-19, HIV and Other Viruses with Gene and Cell Therapies

July 27, 2020

Deploying CRISPR against hidden HIV reservoirs Excision BioTherapeutics is applying both CRISPR and AAV delivery toward solving a different but equally vexing problem in antiviral drug development: HIV. Even though antiretroviral drugs can tamp down the virus to the point where it’s no longer detectable in the blood, it can hide out in “reservoirs” and […]

Read More

Previous Next